We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Aluminum Base Plate Ensures Uniform Microplate Temperature Control

By LabMedica International staff writers
Posted on 04 Apr 2012
Drug developers and other researchers who need to perform high throughput studies involving volatile solvents or that require uniform control of sample temperature will be interested in a newly patented line of aluminum and glass microplates.

The J. More...
G. Finneran (Vineland, NJ, USA) 96-well Aluminum Microplate System was developed for use with volatile solvents and for testing that requires uniform heating and cooling of samples. Protocols involving high throughput solubility testing, salt screening, and freeze-drying are accomplished more effectively with this system than with plastic microplates.

The system is available with either a solid aluminum base plate or one that is vented. The system adheres to the standard eight by 12 (96-well) footprint with a stamped alpha-numeric ID grid. A choice of glass conical and flat bottom vials in four sizes: 0.5 mL, 1.0 mL, 1.5 mL, and 2.0 mL is available. An aluminum cover can be screwed into place, locking vials into the base plate.

Immersion of the vented base plate in liquids allows total fluid contact with the vials, and the aluminum composition of the base plate promotes more efficient heat transfer. The base plate is composed of reusable anodized aluminum that prevents finger print smudges and guarantees an extended lifetime.

“We have learned that medicinal chemists have been looking for a reusable product that offers excellent heat transfer for their solubility and salt selection studies,” said Janet Cohen, international sales and marketing manager at J.G. Finneran. “For example, an estimated 50% of all drug molecules are administered as salts, so we believe this product will be adopted in many drug development assays.”

Related Links:

J. G. Finneran




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.